SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28 | -50.9% | 11,835 | 0.0% | 0.00% | – |
| Q2 2023 | $57 | +3.6% | 11,835 | +21.2% | 0.00% | – |
| Q1 2023 | $55 | -12.7% | 9,768 | -13.1% | 0.00% | -100.0% |
| Q4 2022 | $63 | -99.9% | 11,244 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $72,000 | +89.5% | 11,244 | +1.6% | 0.00% | – |
| Q2 2022 | $38,000 | -53.1% | 11,065 | -2.4% | 0.00% | -100.0% |
| Q1 2022 | $81,000 | -60.3% | 11,332 | -53.9% | 0.00% | 0.0% |
| Q4 2021 | $204,000 | +131.8% | 24,576 | +94.6% | 0.00% | 0.0% |
| Q3 2021 | $88,000 | -71.9% | 12,626 | -3.9% | 0.00% | -66.7% |
| Q2 2021 | $313,000 | +48.3% | 13,143 | +52.5% | 0.00% | -62.5% |
| Q4 2020 | $211,000 | -9.8% | 8,621 | +4.4% | 0.01% | -20.0% |
| Q3 2020 | $234,000 | – | 8,254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $143,316,000 | 50.54% |
| ARK Investment Management | 765,191 | $8,647,000 | 1.68% |
| Rock Springs Capital Management LP | 220,000 | $2,486,000 | 0.13% |
| Artal Group S.A. | 600,000 | $6,780,000 | 0.12% |
| Virtus ETF Advisers LLC | 29,324 | $331,000 | 0.05% |
| FEDERATED HERMES, INC. | 748,568 | $8,459,000 | 0.02% |
| PDT Partners, LLC | 25,500 | $288,000 | 0.01% |
| Baker Brothers Advisors | 125,000 | $1,413,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 527,261 | $5,958,000 | 0.01% |
| FMR LLC | 6,056,294 | $68,436,000 | 0.01% |